Cyclooxygenase-2 expression in proliferative Ki-67-positive breast cancers is associated with poor outcomes.
about
Fatty acid metabolites in rapidly proliferating breast cancerEffect of cycloxygenase-2 silencing on the malignant biological behavior of MCF-7 breast cancer cells.Stromal, rather than epithelial cyclooxygenase-2 (COX-2) expression is associated with overall survival of breast cancer patients.Prognostic influence of cyclooxygenase-2 protein and mRNA expression in node-negative breast cancer patients.The potential role of COX-2 in cancer stem cell-mediated canine mammary tumor initiation: an immunohistochemical study.Targeting the COX-2 Pathway to Improve Therapeutic Response in the Obese Breast Cancer Patient PopulationHigh expression levels of COX-2 and P300 are associated with unfavorable survival in laryngeal squamous cell carcinomaNew Insights on COX-2 in Chronic Inflammation Driving Breast Cancer Growth and Metastasis.EP4 receptor promotes invadopodia and invasion in human breast cancer.Expression of Cox-2 in human breast cancer cells as a critical determinant of epithelial-to-mesenchymal transition and invasiveness.High COX-2 expression is associated with increased angiogenesis, proliferation and tumoural inflammatory infiltrate in canine malignant mammary tumours: a multivariate survival study.A Comparative Approach of Tumor-Associated Inflammation in Mammary Cancer between Humans and Dogs.The prognostic impact of COX-2 expression in breast cancer depends on oral contraceptive history, preoperative NSAID use, and tumor size.Increased COX-2 expression in epithelial and stromal cells of high mammographic density tissues and in a xenograft model of mammographic density.
P2860
Q21090755-E0397871-FD26-4F53-90DD-781FC83C6555Q34141566-6DF9EC4B-3F5E-4AFF-B6CB-3B0A8AC7A6BDQ34316720-9F60D94D-A9F2-47CE-9282-6343DC0A5A0EQ34996098-EDE6F902-28EE-41FF-9E7C-26B2912F65C9Q35790286-DC2CDCE4-63FD-4247-A603-553936D2960EQ36114823-24C24CE3-6C48-45F7-9F34-902A63A5C85BQ36632043-977C64C7-B00B-4690-B33A-331021353C55Q38550876-3F8443F2-405E-49FB-90E0-800875D92711Q38720995-A7DE5BC7-5EDA-4B1A-9E31-64A2F01048B3Q39044750-E0403701-AB75-44E3-9A78-44A6277EA479Q40080923-2B01FAF1-1424-4B63-BC26-3E792D897DB2Q42344612-B77561F8-A4AA-4EC7-9518-A132C9D5312EQ47273449-97DE9DA6-DD98-4696-A2C2-36D18E0DA48CQ53400538-DAC16417-A761-4D80-80D1-2FD8B64C68B4
P2860
Cyclooxygenase-2 expression in proliferative Ki-67-positive breast cancers is associated with poor outcomes.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh-hant
name
Cyclooxygenase-2 expression in ...... associated with poor outcomes.
@en
Cyclooxygenase-2 expression in ...... associated with poor outcomes.
@nl
type
label
Cyclooxygenase-2 expression in ...... associated with poor outcomes.
@en
Cyclooxygenase-2 expression in ...... associated with poor outcomes.
@nl
prefLabel
Cyclooxygenase-2 expression in ...... associated with poor outcomes.
@en
Cyclooxygenase-2 expression in ...... associated with poor outcomes.
@nl
P2093
P2860
P1476
Cyclooxygenase-2 expression in ...... associated with poor outcomes.
@en
P2093
Byeong-Woo Park
Hyewon Hwang
Hyung Seok Park
Ja Seung Koo
Jun Sang Lee
Kyong Sik Lee
Seung Il Kim
Woo Ick Yang
P2860
P2888
P304
P356
10.1007/S10549-012-1971-2
P407
P577
2012-06-01T00:00:00Z